Colette Magnant, MD, FACS

Colette Magnant, MD, FACS is a highly skilled breast surgical oncologist at Maryland Oncology Hematology. She is board certified in general surgery, specializing in advanced surgical techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries.

After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is the director at the Sullivan Center for Breast Health, as well as an assistant professor at Johns Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.

Dr. Magnant believes in evidence-based, state-of-the-art, multidisciplinary breast cancer treatment. She has been treating breast cancer for over 34 years, and this wealth of experience allows her to treat many specialized disorders related to breast health, providing her patients with compassionate and thorough medical care

Adam Goldrich, M.D.

Dr. Adam Goldrich attended Binghamton University, renowned as one of the top public research universities in the U.S., where he received a Bachelor of Science degree in Chemistry and then attended Tel Aviv University – Sackler School of Medicine, a global leader in cancer and molecular biomedical research. As a medical student, he worked at a specialized clinic that provides medical care for undocumented immigrants administered by the internationally renowned Physicians for Human Rights. Upon graduating from medical school, he completed his internal medicine residency at SUNY Downstate Health Sciences University. Following his residency he was elected by his peers to be the Chief Resident at the world-renowned Kings County Hospital in Brooklyn, NY. Dr. Goldrich then trained as a fellow in medical oncology and hematology at Temple University Hospital’s Fox Chase Cancer Center, a National Cancer Institute designated Comprehensive Cancer Center research facility, that boasts two Nobel Prize faculty members who have brought about critical breakthroughs in cancer treatments.

While training at the Fox Chase Cancer Center, he was actively involved in clinical trials, many of which focused on immunotherapeutic treatments in cancer care. In 2018, soon after his fellowship, Dr. Goldrich joined the medical staff at Anne Arundel Medical Center and was actively involved in thoracic oncology research trials as a member of the Chest Steering Committee. Dr. Goldrich is board certified in medical oncology, hematology, and internal medicine.

Dr. Goldrich has leveraged his oncology and hematology expertise for continuing research in the use of immunotherapy and has given specific attention to comprehensive genomic tumor profiling and targeted therapies for the treatment of cancer. His clinical focus is on gastrointestinal cancers such as esophageal, stomach, pancreatic, liver, and colorectal cancers. He also has a focus on lung cancer, head and neck cancer, leukemia, and lymphoma.

“While growing up, I had many close family members who were diagnosed with cancer. I watched them go through the course of their illness and receive various chemotherapy treatments. These personal experiences stayed with me, inspiring me to apply to medical school with the goal of becoming an oncologist.”

Dr. Goldrich believes strongly in the autonomy of his patients. He understands the need for, and truly enjoys, developing close relationships with his patients and their families. He prides himself on always being available to his patients for both clinical and non-clinical issues that might arise.

Dr. Goldrich was born in New York City and raised in central New Jersey. He currently lives in Maryland with his wife and 2 young children. He enjoys spending time with his family and reading to his son and daughter. He also enjoys traveling, trail running and basketball. Of note, he won his NCAA tournament bracket in 2021.

Carol Tweed, M.D.

Carol Tweed, MD joined Maryland Oncology Hematology in October 2020. Dr. Carol Tweed attended Duke University, where she was inducted into Phi Beta Kappa. She graduated summa cum laude with a degree in Biology, and a concentration in molecular biology. She received her medical degree from Washington University in St. Louis, where she was elected to Alpha Omega Alpha. She then completed her Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Pennsylvania.

From 2006-2012, Dr. Tweed was an Assistant Professor on faculty at the University of Pennsylvania’s Abramson Cancer Center. During this time, she practiced as a breast oncology specialist and enthusiastically educated medical students, residents, and fellows.

In 2012, she moved to Annapolis, MD, and joined AAMC Oncology & Hematology, before joining Maryland Oncology Hematology in October 2020. Dr. Tweed passionately cares for patients with a broad range of hematologic and oncologic disorders. Her work as a breast medical oncology expert continues.  She is a regional speaker on the topics of breast cancer and cancer genomics. She is co-founder and co-director of the Maryland Breast Cancer Consortium.

Dr. Tweed is an active clinical researcher; she has served as principal investigator on numerous national and international clinical trials. She also is an Instructor of Medicine/preceptor for Johns Hopkins School of Medicine, educating medical students.

Dr. Tweed is board certified in Hematology and Medical Oncology.



Benjamin Bridges, M.D.

Benjamin Bridges, MD, joined Maryland Oncology Hematology in October 2020. Dr. Bridges completed his medical school at the University of Tennessee in 2001. Dr. Bridges went on to complete his internship at the University of Maryland and his fellowship at the University of Maryland’s Marlene & Stewart Greenbaum Comprehensive Cancer Center. Before joining Maryland Oncology Hematology, Dr. Bridges practiced at St. Luke’s Cancer Institute in Boise, Idaho, for 11 years where he served as Chairman of the Department of Oncology, Research Director for the Cancer Institute, and medical director for St. Luke’s Cancer Institute in Meridian, Idaho.  In his role as Research Director for the Cancer Institute, he served as a principal investigator for the Pacific Cancer Research Consortium, one of the largest National Cancer Institute Community Oncology Research Programs in the country.

David Weng, M.D., Ph.D.

David E. Weng, MD, Ph.D. joined Maryland Oncology Hematology October 2020. Dr. Weng is a board-certified medical oncologist with expertise in clinical care and research for patients with many kinds of solid tumor and hematologic diseases since completing medical school at Johns Hopkins University School of Medicine in 1992. He graduated from Harvard College in 1984 with a degree in biochemical sciences.

Dr. Weng provides compassionate and state-of-the-art patient care that is devoted to understanding, effectively communicating, and fully meeting the needs of each person and his/her family.  He has practiced at leading academic medical centers such as the Cleveland Clinic, the National Cancer Institute, and Johns Hopkins Hospital, and in community medical centers throughout Maryland and Ohio.  He has been an educator of the next generation of oncologists, directing the hematology/oncology fellowship training program at the Cleveland Clinic.

He has extensive research expertise in the laboratory and in clinical trials through his work in the pharmaceutical industry and leading academic institutions, with many publications, patents and invited talks during his career.  He continues his work in clinical research as a member of the many clinical trials offered by Maryland Oncology Hematology and assisting patients to find and evaluate options at leading academic medical centers.

Jeanine L Werner, M.D.

Dr. Jeanine Werner graduated from Tufts University and received her medical degree from Columbia University College of Physicians and Surgeons in New York City. She completed her residency at NYU Medical Center in New York City where she worked extensively with AIDS patients, during the height of the epidemic, learning how to treat the whole patient from an internal medicine perspective.  Her residency was followed by her Medical Oncology and Hematology Fellowship at Memorial Sloan-Kettering Cancer Center in New York where she focused on breast and GI cancers, participating in multiple clinical trials, some of which have translated into advanced cancer treatments. Dr. Werner then returned to Maryland and has been practicing Medical Oncology and Hematology in Annapolis since 1998, practicing for a decade at Anne Arundel Medical Center’s DeCesaris Cancer Institute, most recently joining Maryland Oncology Hematology specializing in breast, gynecologic, and gastrointestinal malignancies, and benign hematology. Dr. Werner is board certified in Medical Oncology and Hematology and is privileged at University of Maryland Baltimore Washington Medical Center. She has been a recipient of an American Society of Clinical Oncology (ASCO) award and has won the peer appointed What’s Up Magazine’s Annapolis Top Doc award.  

“It is a privilege to be able to be entrusted by people when facing the scariest thing they have ever faced. I take an evidence based and guideline-based approach and try to tailor a plan that takes both objective data and subjective needs into account. I am direct, honest and kind…reassuring by helping the patient to understand what our goals and limitations are, so they feel empowered to make decisions based on that information.”  

Dr. Werner was born in New York City and grew up in Silver Spring, Maryland. She currently lives in Davidsonville and is married to internal medicine specialist, Tom Hattar, M.D. who also practices in Annapolis. She has two children, Rebecca, 24 years old, who works on Capitol Hill with an interest in energy policy, and, Mitchell, 21 years old, graduating from college this fall. She enjoys reading novels and particularly loves traveling and exploring new places on foot.   

Stuart Selonick, M.D.

Dr. Stuart E. Selonick is the senior partner at Maryland Oncology Hematology Annapolis and has been practicing Oncology and Hematology for 38 years.

He has a bachelor’s degree from Williams College in Williamstown, Massachusetts, attended medical school at Johns Hopkins University School of Medicine in Baltimore, Maryland, his residency at Johns Hopkins and further training at the National Cancer Institute in Bethesda, Maryland. He then joined the full-time faculty at Johns Hopkins Medicine before going into private practice. He has been consistently recognized locally by the Annapolis Capital newspaper and, most recently, by the magazine, What’s Up Annapolis.

Dr. Selonick resides in Crownsville, Maryland with his wife, a retired cardiologist and his cat. He has three grown children: an oldest daughter is an intensive care specialist at Anne Arundel Medical Center, a middle daughter who is a nursing student and a son who is a writer in Los Angeles, California. He is an avid tennis player, enjoys road biking and plays classical guitar



Peter Graze, M.D.

Dr. Peter Graze is a graduate of Tufts University (Phi Beta Kappa, 1967) and Harvard Medical School (1971).  He completed his internal medicine internship and residency at Massachusetts General Hospital in Boston, MA, and then completed his fellowship in hematology and oncology at the UCLA Center for Health Sciences in Los Angeles, CA.  He served as an Assistant Professor of Medicine at UCLA, where he pioneered autologous bone marrow transplantation and participated in early research on graft versus host disease.  Subsequently, he served as a Professor of Medicine at the University of Nevada School of Medicine. He was Board Certified in Internal Medicine in 1974, in Medical Oncology in 1979, and in Hematology in 1982.

In 1992, Dr. Graze moved to Annapolis and joined a multispecialty group practice that became the Annapolis Oncology Center in 1999. In 2010, he and the other members of that group joined Anne Arundel Medical Center as AAMC Oncology and Hematology. In 2020, Dr. Graze proudly joined his team of colleagues at Maryland Oncology Hematology as part of the Annapolis Office.

Dr. Graze has made the Annapolis area his home and has served as medical Co-Director of Hospice of the Chesapeake for 13 years which helps provide our community hospice & multi-faceted supportive care for our families and their loved ones affected by advanced illness. He has also served as President of the Maryland and District of Columbia Society of Oncology (MDCSCO) for 14 years and currently continues his collaboration with this esteemed group as a Board Member and Treasurer. He continues as a charter member of the American Academy of Hospice and Palliative Medicine.

“As a student, I initially anticipated a career in molecular biology, but found the personal interactions with people and the ability to relieve suffering much more satisfying which led to my calling as a clinician for more than 45 years.”

When not working, you might find Dr. Graze on a local tennis court or playing the 5-string banjo.


Ravin Garg, M.D.

Dr. Ravin Garg attended the University of Michigan—Ann Arbor on a Regents Alumni Scholarship for his undergraduate studies where he received a B.S. degree in Microbiology and was elected into both the Phi Beta Kappa and Phi Kappa Phi Honor Societies. He then attended the nationally top-ranked University of Chicago Pritzker School of Medicine where he was awarded the exclusive Humanism in Medicine Award. After graduating, Dr. Garg returned to his alma mater, the University of Michigan—Ann Arbor, for both his Internship and Internal Medicine Residency. After completing his residency, he worked as an Instructor of Medicine at Johns Hopkins Hospital where he cared for patients and taught the Internal Medicine Residents.

He completed his Hematology and Oncology fellowship at the world-renowned, MD Anderson Cancer Center located in Houston, TX.  It is the #1 Ranked Cancer Center in the United States and he was voted as the top graduating Oncology Fellow.  Due to his love and passion for teaching, he was elected and served as the Chief Fellow for Education and won the Best Teaching Award, all the while publishing several research articles that appeared in various prestigious medical journals.

Since his departure from the MD Anderson Cancer Center, he continues to be invited as a regular speaker at the MD Anderson Board Review Course where hundreds of Hematologists and Oncologists from across the country attend this highly respected lecture series to prepare for their Hematology and Oncology Board Examinations. Currently, he serves as an Assistant Professor of Oncology at Johns Hopkins Hospital where he staffs the fellows’ clinic, conducts case-based weekly morning reports, and gives board review lectures.

Dr. Garg’s love of teaching encouraged him to share his extensive knowledge as the founder of  He has personally written over 2,400 Board Review questions and answers covering all of the seminal Hematology and Oncology subjects. It is considered the premier Board Review website in the country having been used by over 10,000 Hematologists Oncologists all over the world, including the fellowship programs at Harvard, MD Anderson Cancer Center, Cleveland Clinic, Mayo Clinic, Johns Hopkins, Memorial Sloan Kettering, and the University of Pennsylvania.

Aside from his many roles, Ravin Jain Garg, M.D. is a board-certified Oncologist and Hematologist who joined Maryland Oncology Hematology in 2020 and has consistently been voted as one of the best Hematologist Oncologists in both What’s Up Annapolis and The Capital’s Annual Reader’s Choice Award.

“My Mom developed ovarian cancer while I was in medical school. That is why I went into Oncology as a field. Working with patients in a time of need, I strive to provide the best, most up-to-date treatment to each patient. I feel strongly in working as a team with other doctors to provide the best care to patients.  In general, I try to be kind and respectful to everyone.”

Dr. Garg was born and raised in Michigan. His greatest joy is spending time with his wife who is a practicing Primary Care doctor in Largo, Maryland, and his two young sons.  His favorite thing to do is to read to his sons every night. Dr. Garg is a voracious reader. He loves to take road trips, visit museums and explore nature while walking through the woods. He also loves to watch movies and is a diehard sports fan.



Evolving Therapies in Breast Cancer

Jason Taksey, M.D.

Dr. Jason Taksey was born in Silver Spring, MD. He attended University of Maryland, College Park, as part of the Honors program, where he was inducted into Phi Beta Kappa and graduated summa cum laude. During his undergraduate programming was when he first discovered an interest in Oncology, while participating in research at the National Cancer Institute in Bethesda, MD. He graduated from the Pennsylvania State University College of Medicine where he received his Doctor of Medicine Degree. While there, he received the Merck Academic Achievement Award. Dr. Taksey completed his Internal Medicine Residency at Temple University Hospital, and his Hematology/Oncology Fellowship at the Fox Chase Cancer Center in Philadelphia, PA.

Dr. Taksey began clinical practice in 2007 where he joined the Annapolis Oncology Center and continued with the group when they joined Anne Arundel Medical Center as AAMC Oncology and Hematology in 2010. From 2009 to 2014, he was concurrently on staff at Johns Hopkins Hospital where he developed expertise in Genitourinary (GU) malignancies (including prostate, bladder, kidney and testicular cancers) under the leadership of one of the thought leaders in the field.

During his time in practice, Dr. Taksey has served as the primary investigator at Anne Arundel Medical Center for multiple clinical trials with a focus on Genitourinary malignancies. He was also an integral part of the hospital cancer committee. He is a published author in a number of peer reviewed medical journals.

Dr. Taksey is a founding partner in the Annapolis division of Maryland Oncology Hematology. Since 2020, he has cared for patients with a broad range of hematologic and oncologic disorders in a state-of-the-art outpatient treatment facility. He regularly attends GU research program meetings for US Oncology and looks forward to bringing a large network of clinical trials to his patients. He maintains a practice philosophy of listening to all patient questions and concerns and taking as much time as is needed to create a personalized treatment plan.

He is board certified in Hematology and Oncology.

He lives in Edgewater, MD with his wife and two children.


Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology